MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Endologix shares fall on missed Q1 projections

Endologix shares fall on missed Q1 projections

By

EndologixEndologix (NSDQ:ELGX) posted first-quarter results that missed the consensus forecast on Wall Street and cut its outlook for the rest of the year.

The company — maker of endovascular stent-grafts for the treatment of abdominal aortic aneurysms (AAA) — reported losses of -$18.1 million, or -90¢ per share, on sales of $28.5 million for the three months ended March 31 for a sales loss of -19.9% compared with Q1 2019.

Earnings per share were -90¢, 20¢ behind The Street, where analysts were looking for sales of $29.7 million.

“Our first-quarter results were impacted by the deferral of AAA procedures related to the COVID-19 pandemic,” CEO John Onopchenko said in a news release. “We are confident that these deferred procedures will be rescheduled once hospitals widen the criteria for treating AAA patients from today’s ’emergent only’ standard.”

“We are taking the necessary actions to prepare for a return to pre-pandemic procedure volume and to provide necessary case support and ongoing execution of our continuous improvement mandate,” Onopchenko said.

Endologix said the COVID-19 pandemic is expected to have a negative impact on its financial results and business operations. The company withdrew its 2020 financial guidance due to the uncertainties surrounding the pandemic.

Shares in ELGX were down 8.41% to 80¢ apiece in morning trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down -0.3%.

In case you missed it

RSS From Medical Design & Outsourcing

  • How COVID-19 changed medical device clinical trials forever
    The success of remote clinical trial oversight opens the door to hybrid approaches and creates new possibilities for the future of trials. DeviceTalks Because of the pandemic, virtually overnight, all players involved in medical device clinical trials had to pivot to virtual monitoring to keep trials going. What impact did remote trial oversight have on… […]
  • Nuvasive launches ALIF 3D printed porous titanium implant
    Nuvasive this week announced that it has launched its Modulus ALIF 3D printed porous titanium implant for anterior lumbar interbody fusion. San Diego-based Nuvasive designed Modulus for enhanced osseointegration, according to the company. It has a porous surface architecture engineered for fusion and promotes new bone on-growth and in-growth. The design also allows for enhanced… […]
  • Cardinal Health subsidiary faces federal lawsuit over EtO plant in Georgia
    Nearly two dozen people who have lived in the Augusta, Ga. area are suing Cardinal Health subsidiary Kendall Patient Recovery U.S. over ethylene oxide emissions from a medical device sterilization plant in the city. The people suing KPR U.S. in U.S. District Court in Southern Georgia lived and worked within miles of the Augusta facility… […]
  • FDA seeks expanded authority to boost medical device supply chain
    The FDA announced as part of its annual budget proposal that it will include $21.6 million for a new Resilient Supply Chain and Shortages Prevention Program (RSCSPP). Funding from the RSCSPP for the Center for Devices and Radiological Health (CDRH) will provide — the FDA says, for the first time — resources to establish a… […]
  • Using RVI to prevent contamination and maintain purity of pharmaceuticals 
    Here’s how remote visual inspection (RVI) can help pharma companies prevent contamination and maintain product-line purity requirements. Hafees Fraisada, Olympus Bacterial or foreign-particle contamination in production-line equipment can cause serious health issues for consumers and shake public confidence in the industry. Strict purity and contamination control of pharmaceutical manufacturing facilities is required under various international… […]
  • The 18 most innovative medical devices of 2021
    The Galien Foundation today announced the nominees for most innovative medical devices for its 15th annual Prix Galien USA Awards. The foundation nominates devices, biotechnology and pharmaceutical products for its annual Prix Galien awards to highlight products designed to improve the human condition. “The Awards Committee is excited to introduce the nominees for the 2021… […]
  • Stäubli Robotics appoints new pharma and medical device head
    The mechatronics and robotics company Stäubli (Pfäffikon, Switzerland) has named Olivier Cremoux to be the deputy head of pharma and medical device for Stäubli Robotics North America. Cremoux has worked in various Stäubli divisions since 2015 and has served as an international business development manager. In 2018, he began a stint as a North American… […]
  • Novanta acquires ATI Industrial Automation and its surgical robotics tech
    Novanta today announced that it has agreed to acquire ATI Industrial Automation for $172 million in cash. Bedford, Mass.–based Novanta plans to acquire the OEM surgical robotics supplier for $172 million upfront in cash and additional contingent cash payments associated with company financial performance in 2021. The company will also grant performance stock units. ATI… […]
  • Dexcom CEO Kevin Sayer says G7 will be ‘wonderful’
    As we enter what may be the “new normal,” Dexcom’s CEO bets the company can pave the way in continuous glucose monitoring. Dexcom (NSDQ:DXCM), like any company seeking to innovate, remains in a state of perpetual forward motion. That’s the way chair, president & CEO Kevin Sayer views it, anyway. As the company looks toward the… […]
  • How to better clean fiber optics in medical devices
    When it comes to fiber optics in medical devices, cleaning is essential for reliability. Jay Tourigny, MicroCare The use of fiber optics in the medical industry is steadily increasing. As the population continues to grow and age, healthcare providers are using fiber optic devices for better patient diagnosis, monitoring and treatment. Today fiber optics are… […]
  • 7 ways to ensure your medical device product design isn’t biased
    Correcting unintentional biases in medical device product design is a big step toward improving equity in medtech. Achuta Kadambi, an assistant professor at the UCLA Samueli School of Engineering, says when looking at bias in medical devices, there’s often a lot of narrative in the media of what it is. However, it’s also important to… […]